Streetbeat News

Earnings

TEL

TE Connectivity (NYSE:TEL) reported Q2 2024 adjusted EPS of $1.86, surpassing the $1.83 estimate, and sales of $3.967B, slightly above the $3.956B estimate. This represents a 12.73% increase in EPS and a 4.64% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:02 am

BG

Bunge (NYSE:BG) reported Q1 adjusted earnings of $3.04 per share, surpassing the $2.53 estimate, but saw a 6.75% decrease from last year's earnings. Sales were $13.42B, missing the $13.96B estimate and marking a 12.47% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:02 am

SYF

Synchrony Financial (SYF) reported Q1 2024 adjusted earnings per share (EPS) of $1.18, missing the consensus estimate of $1.35 by 12.59%.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:02 am

EDU

ENPH

EQX

EVO

JXN

LAD

NCI

RVTY

Enphase Energy, Inc. (ENPH) reported Q1 financial results below expectations and issued Q2 revenue guidance below estimates, causing its shares to fall 7.3% in pre-market trading. Other stocks such as Evotec SE (EVO), Neo-Concept International Group Holdings Limited (NCI), Equinox Gold Corp. (EQX), Revvity, Inc. (RVTY), Jackson Financial Inc. (JXN), Lithia Motors, Inc. (LAD), and New Oriental Education & Technology Group Inc. (EDU) also recorded losses in pre-market trading due to various reasons including disappointing earnings and acquisition news.

Portfolio Pulse from Avi Kapoor

April 24, 2024 | 10:02 am

HLT

Hilton Worldwide Holdings (HLT) reported Q1 2024 adjusted earnings per share of $1.53, surpassing the consensus estimate of $1.42. Quarterly sales reached $2.573 billion, exceeding expectations of $2.550 billion and marking a 12.21% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:01 am

VRT

Vertiv Holdings has increased its forecast for FY24 adjusted EPS to $2.29 - $2.35, up from the previous range of $2.20-$2.26, compared to analyst expectations of $2.30.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:01 am

TMO

Thermo Fisher Scientific (TMO) reported Q1 2024 adjusted EPS of $5.11, surpassing the $4.71 estimate, and sales of $10.340B, exceeding the $10.170B estimate. This represents a 1.59% increase in EPS and a 3.45% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:00 am

VRT

Vertiv Holdings has increased its FY24 revenue guidance to a range of $7.54B to $7.69B, up from the previous forecast of $7.515B to $7.655B, compared to analysts' expectations of $7.63B.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:00 am

VRT

Vertiv Holdings (VRT) reported Q1 adjusted EPS of $0.43, surpassing the $0.36 estimate, and sales of $1.64B, exceeding the $1.62B estimate. This represents a 79.17% increase in EPS and a 7.75% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 9:56 am

NVS

Novartis and Medicines for Malaria Venture announced positive results from the Phase 2/3 CALINA study, showing that their formulated Coartem for babies under 5kg with malaria has the necessary pharmacokinetic profile, efficacy, and safety.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 9:37 am